Canada Pension Plan Investment Board
NMRA icon

Canada Pension Plan Investment Board’s Neumora Therapeutics NMRA Stock Holding History

Canada Pension Plan Investment Board’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$337K Buy
198,400
+58,200
+42% +$111K ﹤0.01% 1411
2026
Q1 		$273K Buy
140,200
+48,500
+53% +$126K ﹤0.01% 1457
2025
Q4 		$164K Buy
+91,700
New +$201K ﹤0.01% 1724
2025
Q3 		– Sell
-55,700
Closed -$40.8K – 1439
2025
Q2 		$40.8K Buy
+55,700
New +$42.2K ﹤0.01% 1276

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Canada Pension Plan Investment Board's NMRA Position: Q2 2026 in Review

Canada Pension Plan Investment Board increased its Neumora Therapeutics (NMRA) stake by 42% in Q2 2026, buying an estimated $111K and bringing the position to 198,400 shares worth $337K. The position accounts for ﹤0.01% of the portfolio, ranked #1411.

Canada Pension Plan Investment Board first reported a position in NMRA in Q2 2025 and has held it in 4 quarters since. 113 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

  • Canada Pension Plan Investment Board held 198,400 shares of Neumora Therapeutics worth $337K as of Q2 2026.
  • Canada Pension Plan Investment Board bought 58,200 Neumora Therapeutics shares in Q2 2026, an estimated $111K.
  • Neumora Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1411 holding.
  • Canada Pension Plan Investment Board first reported a position in Neumora Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 113 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.